Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · March 10, 2024

Validation of the Prognostic Performance of the Breast Cancer Index in Postmenopausal Women With HR+ Breast Cancer

Clinical Cancer Research

 

Additional Info

Clinical Cancer Research
Validation of the prognostic performance of Breast Cancer Index (BCI) in hormone receptor-positive (HR+) postmenopausal breast cancer patients in the TEAM trial
Clin. Cancer Res 2024 Feb 12;[EPub Ahead of Print], JMS Bartlett, K Xu, J Wong, G Pond, Y Zhang, M Spears, R Salunga, E Mallon, KJ Taylor, A Hasenburg, C Markopoulos, L Dirix, CJH van de Velde, D Rea, CA Schnabel, K Treuner, J Bayani

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading